Total Payments
$4,777
2024 Payments
$497.60
Companies
42
Transactions
196
Medicare Patients
9,977
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$4,044 (84.6%)
Travel$585.89 (12.3%)
Education$147.73 (3.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,044 | 188 | 84.6% |
| Travel and Lodging | $585.89 | 3 | 12.3% |
| Education | $147.73 | 5 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $1,015 | 13 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $489.67 | 22 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $456.38 | 26 | $0 (2024) |
| Merck Sharp & Dohme LLC | $393.83 | 20 | $0 (2024) |
| Medtronic, Inc. | $297.08 | 5 | $0 (2024) |
| Amarin Pharma Inc. | $228.94 | 15 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $198.96 | 9 | $0 (2022) |
| Esperion Therapeutics, Inc. | $140.31 | 7 | $0 (2024) |
| Allergan Inc. | $130.47 | 4 | $0 (2018) |
| Paratek Pharmaceuticals, Inc. | $113.57 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $497.60 | 24 | Alexion Pharmaceuticals, Inc. ($77.75) |
| 2023 | $776.57 | 33 | AstraZeneca Pharmaceuticals LP ($205.36) |
| 2022 | $916.90 | 38 | Medtronic, Inc. ($195.34) |
| 2021 | $410.23 | 23 | Medtronic, Inc. ($83.80) |
| 2020 | $453.99 | 24 | Amarin Pharma Inc. ($144.58) |
| 2019 | $1,257 | 28 | Medtronic Vascular, Inc. ($916.10) |
| 2018 | $281.19 | 14 | Allergan Inc. ($84.77) |
| 2017 | $183.61 | 12 | Allergan Inc. ($45.70) |
All Payment Transactions
196 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $29.39 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Oncology | ||||||
| 09/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/06/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: Nephrology | ||||||
| 07/17/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: EndoVenous Therapies | ||||||
| 06/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/23/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $26.51 | General |
| Category: Rare Disease | ||||||
| 05/16/2024 | Ethicon US, LLC | STRATAFIX (Device), DERMABOND | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Wound Closure | ||||||
| 04/29/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/23/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $26.98 | General |
| Category: Rare Disease | ||||||
| 04/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: DIABETES | ||||||
| 04/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Diabetes Care | ||||||
| 03/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Cardio-renal | ||||||
| 03/20/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: Rare Disease | ||||||
| 03/01/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Oncology | ||||||
| 02/20/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Nephrology | ||||||
| 02/13/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $34.59 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 02/02/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/23/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/28/2023 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: WATCHMAN FLX_IC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,990 | 2,954 | $519,245 | $240,075 |
| 2022 | 19 | 1,980 | 2,909 | $512,850 | $243,473 |
| 2021 | 28 | 2,696 | 3,820 | $669,345 | $335,694 |
| 2020 | 22 | 3,311 | 4,815 | $820,470 | $399,785 |
Total Patients
9,977
Total Services
14,498
Medicare Billing
$1.2M
Procedure Codes
88
All Medicare Procedures & Services
88 procedure records from CMS Medicare Utilization — Page 2 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2022 | 121 | 121 | $12,705 | $5,939 | 46.7% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 33 | 33 | $9,735 | $4,574 | 47.0% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 96 | 112 | $7,840 | $4,478 | 57.1% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2022 | 115 | 115 | $4,600 | $2,037 | 44.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 35 | 42 | $3,570 | $1,275 | 35.7% |
| 93280 | Programming of dual lead pacemaker system | Office | 2022 | 16 | 21 | $1,890 | $1,213 | 64.2% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2022 | 111 | 111 | $2,775 | $1,103 | 39.8% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2022 | 28 | 52 | $2,080 | $837.05 | 40.2% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2022 | 20 | 34 | $1,700 | $746.37 | 43.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 60 | 60 | $1,500 | $613.11 | 40.9% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2022 | 23 | 23 | $1,035 | $445.31 | 43.0% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2022 | 19 | 20 | $500.00 | $202.34 | 40.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 39 | 42 | $420.00 | $124.38 | 29.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 520 | 910 | $177,390 | $84,911 | 47.9% |
| 78452 | Nuclear medicine study of vessels of heart using drugs or exercise multiple studies | Office | 2021 | 161 | 161 | $112,700 | $58,951 | 52.3% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 379 | 385 | $115,500 | $57,585 | 49.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2021 | 161 | 644 | $57,960 | $30,669 | 52.9% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2021 | 161 | 322 | $59,570 | $30,267 | 50.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 180 | 180 | $45,900 | $22,248 | 48.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 189 | 228 | $37,620 | $19,725 | 52.4% |
| 93015 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report | Office | 2021 | 161 | 161 | $16,905 | $7,924 | 46.9% |
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Office | 2021 | 43 | 43 | $12,685 | $6,671 | 52.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 49 | 52 | $7,280 | $3,799 | 52.2% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2021 | 125 | 128 | $5,120 | $2,389 | 46.7% |
| 93280 | Evaluation, testing, and programming adjustment of permanent dual lead pacemaker system with physician analysis, review, and report | Office | 2021 | 24 | 35 | $3,150 | $2,081 | 66.1% |
About Dr. Michael Chesner, MD
Dr. Michael Chesner, MD is a Cardiovascular Disease healthcare provider based in Summerfield, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154355766.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Chesner, MD has received a total of $4,777 in payments from pharmaceutical and medical device companies, with $497.60 received in 2024. These payments were reported across 196 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($4,044).
As a Medicare-enrolled provider, Chesner has provided services to 9,977 Medicare beneficiaries, totaling 14,498 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 88 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Summerfield, FL
- Active Since 07/10/2006
- Last Updated 01/11/2018
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1154355766
Products in Payments
- CareLink (Device) $658.52
- ENTRESTO (Drug) $273.44
- Amplia MRI (Device) $260.55
- BRILINTA (Drug) $242.78
- VERQUVO (Drug) $232.99
- Vascepa (Drug) $228.94
- XARELTO (Drug) $198.96
- LEQVIO (Drug) $182.94
- LINQ II (Device) $172.50
- FARXIGA (Drug) $158.80
- Micra (Device) $149.32
- NEXLETOL (Drug) $121.98
- NUZYRA (Drug) $113.57
- ELIQUIS (Drug) $112.10
- LifeVest (Device) $108.94
- BELSOMRA (Drug) $104.15
- OPTIMIZER (Device) $96.87
- JARDIANCE (Drug) $87.05
- AVYCAZ (Drug) $84.77
- ULTOMIRIS (Biological) $77.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.